Source link : https://www.newshealth.biz/health-news/muc-1-vaccine-shows-notable-overall-survival-rates-in-bc/
The MUC-1 vaccine tecemotide plus standard neoadjuvant systemic therapy was shown to notably improve distant relapse-free survival and overall survival rates in breast cancer patients, in a new study. “This is the first successful study of a breast cancer vaccine to date,” Christian F. Singer, MD, said during an interview. Dr Singer, the lead author […]
Author : News Health
Publish date : 2024-07-01 06:44:03
Copyright for syndicated content belongs to the linked Source.
Categories